Gesynta Pharma AB today announced that the first patient has been dosed in its Phase 2 clinical proof-of-concept trial (NOVA) of vipoglanstat, a novel non-hormonal ...

Gesynta Pharma AB today announced that the first patient has been dosed in its Phase 2 clinical proof-of-concept trial (NOVA) of vipoglanstat, a novel ...

GOTHENBURG, Sweden, Jan. 27, 2026 /PRNewswire/ -- "We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the ...

Philips and Getinge aim to combine their respective equipment for patient monitoring and delivering anesthesia into a single workstation, with the goal of simplifying operations in the operating room.

Zimmer Biomet and Getinge are partnering to distribute operating room capital products to ASCs, according to a July 10 news release. The partnership offers a turnkey solution for ASCs that can access ...

Welcome to the Getinge Q4 Report 2024. [Operator Instructions] Now I will hand the conference over to speakers CEO, Mattias Perjos; and CFO, Agneta Palmer. Please go ahead. Thank you very much, and ...

Jan 28 (Reuters) - Swedish medical equipment maker Getinge (GETIb.ST), opens new tab reported fourth-quarter core earnings above market expectations on Tuesday, supported by solid growth in order ...

Welcome to the Getinge Q3 Report 2023. [Operator Instructions]. Now I will hand the conference over to the speakers, CEO, Mattias Perjos; and CFO, Agneta Palmer. Please go ahead. Thank you very much, ...

Getinge, a Swedish public limited company, announced on September 11, 2024 that it completed acquisition of Paragonix Technologies, Inc., a U.S. company specializing in organ transport products and ...

Getinge has today completed the previously announced acquisition of 100% of the shares of Paragonix Technologies, Inc. The total market for transplants has been growing rapidly in recent years and is ...